[go: up one dir, main page]

WO2010023690A3 - Formulation à libération prolongée d'amisulpride - Google Patents

Formulation à libération prolongée d'amisulpride Download PDF

Info

Publication number
WO2010023690A3
WO2010023690A3 PCT/IN2009/000471 IN2009000471W WO2010023690A3 WO 2010023690 A3 WO2010023690 A3 WO 2010023690A3 IN 2009000471 W IN2009000471 W IN 2009000471W WO 2010023690 A3 WO2010023690 A3 WO 2010023690A3
Authority
WO
WIPO (PCT)
Prior art keywords
amisulpride
prolonged release
release formulation
relates
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2009/000471
Other languages
English (en)
Other versions
WO2010023690A2 (fr
Inventor
Jaya Abraham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Torrent Pharmaceuticals Ltd
Original Assignee
Torrent Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd filed Critical Torrent Pharmaceuticals Ltd
Publication of WO2010023690A2 publication Critical patent/WO2010023690A2/fr
Publication of WO2010023690A3 publication Critical patent/WO2010023690A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une forme pharmaceutique à libération prolongée qui comprend de l'amisulpride, de préférence sous forme de multiples granules unitaires ou de microcomprimés, prévus dans une capsule ou comprimés pour former un comprimé ou un comprimé bicouche. L'invention concerne aussi un procédé de préparation de cette forme pharmaceutique.
PCT/IN2009/000471 2008-08-28 2009-08-28 Formulation à libération prolongée d'amisulpride Ceased WO2010023690A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1807/MUM/2008 2008-08-28
IN1807MU2008 2008-08-28

Publications (2)

Publication Number Publication Date
WO2010023690A2 WO2010023690A2 (fr) 2010-03-04
WO2010023690A3 true WO2010023690A3 (fr) 2010-06-03

Family

ID=41722052

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000471 Ceased WO2010023690A2 (fr) 2008-08-28 2009-08-28 Formulation à libération prolongée d'amisulpride

Country Status (1)

Country Link
WO (1) WO2010023690A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200110648A (ko) 2017-12-05 2020-09-24 선오비온 파마슈티컬스 인코포레이티드 비라세믹 혼합물 및 이의 용도
CN118955352A (zh) 2017-12-05 2024-11-15 赛诺维信制药公司 晶体形式及其制备方法
CN109010300A (zh) * 2018-10-24 2018-12-18 湖南洞庭药业股份有限公司 一种氨磺必利片及其制备方法
MX2021014774A (es) * 2019-06-04 2022-02-03 Sunovion Pharmaceuticals Inc Formulaciones de liberacion modificada y usos de las mismas.
US20220323409A1 (en) * 2019-06-04 2022-10-13 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof
CN115487161B (zh) * 2022-11-18 2023-03-03 山东则正医药技术有限公司 一种氨磺必利片的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62178518A (ja) * 1986-01-30 1987-08-05 Toho Yakuhin Kogyo Kk 新規持続性スルピリド錠剤
US20010046473A1 (en) * 1997-04-18 2001-11-29 Jerome Besse Gastric-retained pharmaceutical composition and method for its use
US20060153925A1 (en) * 2003-07-09 2006-07-13 Sanofi-Aventis Novel solid pharmaceutical composition comprising amisulpride
US20080188537A1 (en) * 2007-02-02 2008-08-07 Jean-Michel Azorin Method of treating bipolar depression with a benzamide derivative

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62178518A (ja) * 1986-01-30 1987-08-05 Toho Yakuhin Kogyo Kk 新規持続性スルピリド錠剤
US20010046473A1 (en) * 1997-04-18 2001-11-29 Jerome Besse Gastric-retained pharmaceutical composition and method for its use
US20060153925A1 (en) * 2003-07-09 2006-07-13 Sanofi-Aventis Novel solid pharmaceutical composition comprising amisulpride
US20080188537A1 (en) * 2007-02-02 2008-08-07 Jean-Michel Azorin Method of treating bipolar depression with a benzamide derivative

Also Published As

Publication number Publication date
WO2010023690A2 (fr) 2010-03-04

Similar Documents

Publication Publication Date Title
IL225637A0 (en) The compositions, tablets containing such compositions, their use and a process for their preparation
WO2010023690A3 (fr) Formulation à libération prolongée d'amisulpride
CL2013001586A1 (es) Composicion microgranular de rapida dispersion que comprende al menos un alcohol de azucar, un sacarido, o una mezcla de estos, al menos un super disgregante y al menos un aditivo multifuncion; comprimido de desintegracion oral que comprende la composicion microgranular y al menos un principio activo; y metodos de fabricacion.
WO2011101866A3 (fr) Méthode de traitement d'une affection sensible à une thérapie par baclofène
IL217034A0 (en) Solid drug tablets for implantable drug delivery devices
IL216522A (en) Durable dosage form, packing containing it and method of preparation
IL215826A (en) Pharmaceutical preparation with delayed release, process of preparation of the preparation, use of the preparation for the preparation of pain medication and the pill containing it.
IL224430B (en) Liquid pharmaceutical formulation comprising st-246 and a beta-cyclodextrin, a process of making the liquid formulation, a unit dosage liquid formulation and a process for preparing a water-soluble solid st-246 pharmaceutical formulation
WO2006011159A3 (fr) Composition pharmaceutique stabilisee contenant du sodium de rabeprazole presentant une biodisponibilite amelioree
WO2011104652A3 (fr) Compositions vétérinaires
IL223012B (en) Pharmacy preparations in the form of tablets with two layers containing atorvastatin and irbesartan
WO2010127205A3 (fr) Formulations de combinaison de médicament à dose fixe
WO2007122635A3 (fr) Formulation à libération à libération contrôlée comprenant des médicaments anti-épilepiques
WO2011143118A3 (fr) Formulations résistantes à l'alcool
WO2010043408A3 (fr) Fésotérodine microencapsulée
CA2863376A1 (fr) Comprimes gastro-resistants
WO2009151408A3 (fr) Dispositif d'inhalation facile à utiliser
WO2007097770A8 (fr) Comprimés de succinate de métoprolol er et méthodes pour leur préparation
ZA201109262B (en) Process for the preparation of a spray powder comprising one or more glycine-n,n-diacetic acid derivatives and use of the spray powder for producing compression agglomerates
MX344163B (es) Formulaciones farmacéuticas de loratadina para encapsulación y combinaciones de las mismas.
WO2009149058A8 (fr) Formulations de niacine à libération modifiée
IL213105A (en) Compounds, their preparation process, pharmaceutical preparations containing them and their use in the preparation of drugs
PL2121277T3 (pl) Sposób wytwarzania opakowań dla produktów kosmetycznych, leczniczych, farmaceutycznych i tym podobnych
WO2009060064A3 (fr) Formulations pharmaceutiques pour l'administration par voie orale de ppi
WO2009000473A3 (fr) Comprimés effervescents destinés à être inhalés

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09765170

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 09765170

Country of ref document: EP

Kind code of ref document: A2